|
|
| 30 Apr 2026 | 19:04 IST |
|
Tata India Pharma & Healthcare Fund (IDCW) RI |
|
|
|
|
|
|
|
| NAV Details |
| NAV Date : |
29-Apr-26 |
| NAV [Rs]: |
29.99 |
| Buy/Resale Price [Rs] : |
0.00 |
| Sell/Repurchase Price [Rs] : |
0.00 |
| Max Entry Load % : |
0.00 |
| Max Exit Load % : |
0.00 |
|
|
|
|
|
|
|
|
| Quantum of Dividend % |
NA |
NA |
| Date |
NA |
NA |
|
|
|
|
|
|
| Tax benefits : |
|
| Min. Investment(Rs.) : |
5000 |
| Increm.Investment(Rs.) : |
1000 |
|
|
|
|
|
| Statistical Ratios |
What
is Beta ?
Beta is a measure of the volatility of the portfolio to that of the index. In
simple words it shows the movement of the portfolio in comparison. The Higher
the Beta, higher the volatility of the scheme to the index. If its greater
than1 , then the portfolio is highly volatile to the movemnts in the index. If
the beta is lesser than 1 , then scheme is less volatile to the index and beta
which is close to 1 implies that the scheme is closely following the index.
|
| 0.8341 |
4.8615 |
0.8061 |
13.1469 |
-0.0255 |
|
|
|
|
Sun Pharma.Inds.
|
10.34
|
|
Abbott India
|
5.89
|
|
Divi's Lab.
|
5.83
|
|
Health.Global
|
5.39
|
|
Max Healthcare
|
5.14
|
|
Cipla
|
5.10
|
|
Apollo Hospitals
|
4.25
|
|
Rainbow Child.
|
4.23
|
|
Mankind Pharma
|
3.57
|
|
Bayer Crop Sci.
|
3.51
|
|
Dr Reddy's Labs
|
3.45
|
|
Lupin
|
3.18
|
|
Fortis Health.
|
3.17
|
|
Metropolis Healt
|
3.02
|
|
Dr Lal Pathlabs
|
2.69
|
|
Syngene Intl.
|
2.64
|
|
Sai Life
|
2.58
|
|
Alkem Lab
|
2.45
|
|
J B Chemicals &
|
2.40
|
|
Glaxosmi. Pharma
|
2.14
|
|
Neuland Labs.
|
2.08
|
|
Ajanta Pharma
|
2.04
|
|
Global Health
|
2.01
|
|
FDC
|
1.84
|
|
Sanofi India
|
1.70
|
|
Vijaya Diagnost.
|
1.41
|
|
Krishna Institu.
|
1.34
|
|
Aurobindo Pharma
|
1.20
|
|
Torrent Pharma.
|
1.10
|
|
Corona Remedies
|
0.75
|
|
P & G Health Ltd
|
0.70
|
|
P I Industries
|
0.63
|
|
HDFC Life Insur.
|
0.62
|
|
Tata Chemicals
|
0.50
|
|
Sumitomo Chemi.
|
0.39
|
|
Jubilant Pharmo
|
0.34
|
|
Dr Agarwal's Hea
|
0.07
|
|
Ipca Labs.
|
0.00
|
|
Reverse Repo
|
0.26
|
|
Net CA & Others
|
0.05
|
|
|
|
|
|
|
Asset Allocation
|
|
|
|
 |
|